| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | 24 | 93 | -1.10 | 0.81 | BLENDED GS |
| May 2025 | 73 | 93 | -3.69 | 2.11 | BLENDED GS |
| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | 24 | 93 | -1.10 | 0.81 | BLENDED GS |
| May 2025 | 73 | 93 | -3.69 | 2.11 | BLENDED GS |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 816 | 300 | BLENDED GS |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 300 | 816 | 19066 | 379 | 386 | 88 | 86 |
| May 2025 | 300 | 816 | 19066 | 379 | 386 | 88 | 86 |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 300 | 816 | 19066 | 379 | 386 | 88 | 86 |
| May 2025 | 300 | 816 | 19066 | 379 | 386 | 88 | 86 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 778 | 684 | 589 | 488 | 374 |
| No. Herds | 265 | 259 | 251 | 224 | 194 |
| No. without completed record |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 778 | 684 | 589 | 488 | 374 |
| No. Herds | 265 | 259 | 251 | 224 | 194 |
| No. without completed record |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 816 | 300 | BLENDED GS |
| Country | Fertility | Survival | ||
|---|---|---|---|---|
| Daughters | Herds | Daughters | Herds | |
| AUS | 0 | 0 | 0 | 0 |
| CAN | 0 | 0 | 0 | 0 |
| DFS | 0 | 0 | 0 | 0 |
| FRA | 0 | 0 | 0 | 0 |
| GBR | 382 | 37 | 516 | 50 |
| GER | 0 | 0 | 0 | 0 |
| ITA | 0 | 0 | 0 | 0 |
| NLD | 0 | 0 | 0 | 0 |
| NZL | 175 | 72 | 121 | 52 |
| USA | 0 | 0 | 0 | 0 |